The epigenetic adjustment of miR-142-5p inactivated the PI3K/AKT signaling pathway by targeting PIK3AP1 and inhibiting cervical cancer progression (Guo et al., 2021). The gene discussed is AKT1; the disease is cervical carcinoma.